Diagnostics and genetic analysis business Source BioScience said a good performance in the third quarter meant it was on track to meet full year expectations.
The company said the three months to the end of September had been a period of sustained growth and
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The performance was underpinned by growth in the firm's cytology business (which studies cell structure), driven by the adoption of automated imaging for cervical cancer screening.
The LifeSciences division also took increasing market share for DNA sequencing in the UK.
Source said it was in a robust financial position with £2m cash as of September 30th, up from £1.8m at the end of June.
MM
-
Pensions IHT reform: major changes needed says former ministerExperts are calling on the government to make the system for applying inheritance to pensions ‘more effective, efficient and humane’
-
MoneyWeek turns 25: Vote for your favourite MoneyWeek cover in our pollPoll As MoneyWeek reaches an important milestone, we’re inviting readers to choose their favourite cover from over the years. Vote in our poll.
